Premenstrual dysphoric disorder
ICD-10 F32.81 is a billable code used to indicate a diagnosis of premenstrual dysphoric disorder.
Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS) characterized by significant emotional and physical symptoms that occur in the luteal phase of the menstrual cycle and remit shortly after the onset of menstruation. Clinically, PMDD is marked by mood disturbances such as severe depression, anxiety, irritability, and mood swings, which can significantly impair daily functioning. Physical symptoms may include fatigue, sleep disturbances, and somatic complaints. The diagnosis of PMDD requires the presence of at least five symptoms, including one or more affective symptoms, such as mood swings or irritability, and one or more somatic symptoms, such as breast tenderness or headaches. The condition is thought to be related to hormonal fluctuations and may involve neurotransmitter dysregulation, particularly serotonin. Treatment options often include lifestyle modifications, psychotherapy, and pharmacotherapy, including selective serotonin reuptake inhibitors (SSRIs) and hormonal treatments. Due to the cyclical nature of PMDD, careful assessment of symptom patterns is crucial for accurate diagnosis and effective management.
Detailed psychiatric evaluation notes, including symptom assessment and treatment response.
Patients presenting with severe mood disturbances related to menstrual cycles.
Consideration of comorbid mood disorders and the impact of hormonal treatments.
Menstrual history, symptom tracking, and treatment plans including hormonal therapies.
Patients seeking relief from severe premenstrual symptoms affecting quality of life.
Coordination with mental health providers for comprehensive care.
Used for follow-up visits for PMDD management.
Document symptom review, treatment response, and any changes in management.
Psychiatric and gynecological specialties may require different documentation focuses.
PMDD is a severe form of premenstrual syndrome characterized by significant mood disturbances and functional impairment, whereas PMS includes milder symptoms that do not typically interfere with daily activities.
